Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy

American Journal of Neuroradiology

Volumn 19, Issue 9, 1998, Pages 1681-1686

  Haseler, Luke J ^a   Sibbitt Jr , Wilmer L ^a,b   Mojtahedzadeh, Hossein N ^a   Reddy, Sunil ^a   Agarwal, Vijay P ^a   McCarthy, Denis M ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b New Mexico Federal Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTULOSE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; HUMAN; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN RESTRICTION;

ADMINISTRATION, ORAL; ADULT; BRAIN; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; REFERENCE VALUES;

EID: 0032470817     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fraser CL, Arieff AI. Hepatic encephalopathy. N Engl J Med 1985; 313:865-872
2. Shomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Doelle W. Latent portosystemic encephalopathy, I: nature of cerebral functional defects and fitness to drive. Dig Dis Sci 1981;26:622-630
3. Butterworth RF, Layrargues GP. Hepatic Encephalopathy: Pathophysiology and Treatment. Clifton, NJ: Humana Press; 1989
4. James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma amino acid imbalance, and blood-brain barrier amino acid transport: a unified theory of portal-systemic encephalopathy. Lancet 1979;2:772-775
5. Livingstone AS, Potvin M, Goresky CA, Finlayson MH, Hinchey EJ. Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat. Gastroenterology 1977;73:697-704
6. Schafer DG, Jones EA. Potential neural mechanism in the pathogenesis of hepatic encephalopathy. Prog Liver Dis 1982;7:615-627
7. Ono J, Hutson DG, Dombro RS, Levi JU, Livingstone A, Zeppa R. Tryptophan and hepatic coma. Gastroenterology 1978;74:196-200
8. Kreis R, Farrow N, Ross BD. Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and myo-inositol. NMR Biomed 1991;4:109-116
9. Kreis R, Farrow N, Ross BD. Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet 1990;336:635-636
10. Kreis R, Ross BD, Farrow N, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182:19-27
11. Haseler LJ, Agarwal V, Sibbitt, WL, Brooks WM, Hart BL, Matwiyoff NA. Chronic hepatic encephalopathy: reversal of 1H MR spectra following liver transplantation (abstr). In: Society of Magnetic Resonance in Medicine, 11th Annual Scientific Meeting, Berlin, Germany. San Diego: Society of Magnetic Resonance in Medicine; 1992:1014
12. Geissler A, Farrow NA, Villamil F, et al. Is hepatic encephalopathy reversed by liver transplantation (abstr)? In: Society of Magnetic Resonance in Medicine, 11th Annual Scientific Meeting, Berlin, Germany. San Diego: Society of Magnetic Resonance in Medicine; 1992:647
13. Blanc P, Daures JP, Rouillon JM, et al. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a metaanalysis. Hepatology 1992;15:222-228
14. Jones DB. Hepatic encephalopathy. J Gastroenterol Hepatol 1993; 8:363-369
15. Mortensen PB. The effect of oral-administered lactulose on colonic nitrogen metabolism and excretion. Hepatology 1992;16:1350-1356
16. Van Thiel DH, Fagiuoli S, Wright HI, Chien MC, Gavaler JS. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Hepatology 1994;19:67-71
17. Parsons-Smith BB, Summerskill WHJ, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet 1956;2:867-871
18. Hulley SB, Feigal D, Martin M, Cummings SR. Designing a new study, IV: experiments. In: Hulley SB, Cummings SR, eds. Designing Clinical Research. Baltimore: Williams & Wilkins; 1988:110-127
19. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987;508:333-348
20. Salvan AM, Vion-Dury J, Confort-Gouny S, Nicoli F, Lamoureux S, Cozzone PJ. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy: comparison between sequences using short and long echo times. Invest Radiol 1997;32:485-495
21. Sibbitt WL Jr, Haseler LH, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA. Analysis of cerebral structural changes in systemic lupus erythematosus by proton magnetic resonance spectroscopy. AJNR Am J Neuroradiol 1994;45:923-928
22. Sibbitt WL Jr, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined by proton MR spectroscopy. AJNR Am J Neuroradiol 1997;48:1271-1277
23. Brooks WM, Sabet A, Sibbitt WL Jr. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 1997;24:2323-2329
24. Marshall I, Wardlaw J, Cannon J, Slattery J, Sellar RJ. Reproducibility of metabolite peak areas in 1H MRS of brain. Magn Reson Imaging 1996;14:281-292
25. Ernst T, Ross BD, Flores R. Cerebral MRS in infant with suspected Reyes syndrome (letter). Lancet 1992;340:486
26. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994; 193:457-463
27. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthesis in astrocytes of rat brain. Brain Res 1979;10:171-174
28. Balazs R. Carbohydrate metabolism. In: Lajtha A, ed. Handbook of Neurochemistry. New York: Plenum; 1970;3:13-45
29. Reubi-J-C, van den Berg C, Cuenod M. Glutamine as precursor for the GABA and glutamate transmitter pools. Neurosci Lett 1978;10: 171-174
30. Manev H, Costa E, Wroblewski JT, Guidotti A. Abusive stimulation of excitatory amino acid receptors: a strategy to limit neurotoxicity. FASEB J 1990;4:2789-2797
31. Takahashi H, Koehler RC, Brusilow SL, Traystman RD. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991;261:H825-H829
32. Haussinger D, Laubenberger J, vom Dahl S, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994; 107:1475-1480
33. Clements RS, Vourganti B, Kuba T, Oh SJ, Darnell B. Dietary myo-inositol intake and peripheral nerve malfunction in diabetic neuropathy. Metabolism 1979;28:477-483
34. Lien YH, Michaelis T, Moats RA, Ross BD. Scyllo-inositol depletion in hepatic encephalopathy. Life Sci 1994;54:1507-1512
35. Holub BJ. Metabolism and function of myo-inositol and inositol phospholipids. Annu Rev Nutr 1986;6:563-597
36. Holub BJ. The nutritional importance of inositol and the phosphoinositides. N Engl J Med 1992;326:1285-1287
37. Green DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987;316:599-606
38. Gullans SR, Verbalis JG. Control of brain volume during hyperosmolar and hypo-osmolar conditions. Annu Rev Med 1993;44: 289-301
39. Lien Y-H, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia: implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 1991;88:303-309
40. Lee JH, Arcinue E, Ross BD. Organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 1994;331;439-442
41. Videen JS, Michaelis T, Pinto P, Ross BD. Human cerebral osmolytes during chronic hyponatremia. J Clin Invest 1995;95: 788-793
42. Wijdicks EFM, Plevak DJ, Rakela J, Wiesner RH. Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 1995;70:119-124
43. Naegele T, Seeger U, Klose U, et al. Localized 1H-spectroscopy of the brain with ultra-short echo times in hepatic encephalopathy including follow up after liver transplantation (abstr). In: Proceedings of the International Society for Magnetic Resonance in Medicine. International Society for Magnetic Resonance in Medicine; 1996: 305
44. Ross B, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994;10:191-247